Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

793032

	registered interest
	date	21/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anaemia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State of Health, what steps the Department is taking to promote awareness and improve the rate of diagnosis of anaemia.
	tabling member constituency	North East Derbyshire
	tabling member printed	Lee Rowley
	uin	114817
	answer	answer is ministerial correction date of answer 29/11/2017 answer text <p>Iron deficiency anaemia is the most prevalent type of anaemia and is also the most common deficiency in the world, affecting over 2 billion people worldwide. NHS Choices provides advice on the symptoms of iron deficiency anaemia, such as fatigue, palpitations, pale complexion and advises anyone experiencing those symptoms speak to their general practitioner (GP). NHS Choices also provides advice on the less common types of anaemia related to levels of vitamin B12 or folate.</p><p> </p><p>It is the responsibility of GPs, using their clinical judgement and supported by relevant guidance, to arrange the appropriate tests and investigations that may lead to a diagnosis. The full blood count, one the most commonly used tests in the National Health Service, is a broad screening tool used to provide a picture of patient health and check for indications of disorders such as anaemia, infection, and many other diseases.</p><p> </p><p>A range of guidance on the further testing and treatment of all types anaemia is available from sources including the National Institute for Health and Care Excellence Clinical Knowledge Summaries (CKS) website. The CKS information on iron deficiency anaemia can be found at the following link:</p><p> </p><p><a href="https://cks.nice.org.uk/anaemia-iron-deficiency" target="_blank">https://cks.nice.org.uk/anaemia-iron-deficiency</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2017 14:42:34 answering member 4067 label Biography information for Steve Brine
	tabling member	4652 label Biography information for Lee Rowley

751345

	registered interest
	date	12/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dental Services: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the recently concluded pilot on improving access to primary care dentistry in the Bradford City, Bradford Districts and North Kirklees Clinical Commissioning Group areas, what plans he has to publish his assessment of that pilot; and whether he has plans to provide ongoing funding to improve access to primary care dentistry.
	tabling member constituency	Bradford South
	tabling member printed	Judith Cummins
	uin	4705
	answer	answer is ministerial correction date of answer 17/07/2017 answer text <p>The primary care dental access pilot, which began on 9 January 2017, was established to build additional capacity in dental practices and provide more appointments for the patients of Kirklees, Dewsbury and Bradford.</p><p> </p><p>The scheme, which was originally due to end on 31 March 2017, proved to be successful, so was extended until 30 June 2017. The results of this are currently being analysed and NHS England will make the findings available shortly.</p><p> </p><p>NHS England has also confirmed that a costed commissioning plan, based on these findings and the needs of the population, will be considered by the NHS England Yorkshire and Humber Director team over the summer of 2017 and an approach agreed to improve capacity in identified areas.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/07/2017 12:56:35 answering member 4067 label Biography information for Steve Brine
	tabling member	4391 label Biography information for Judith Cummins

759361

	registered interest
	date	11/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the publication of Towards a smoke-free generation: a tobacco control plan for England in July 2017 by his Department, if he will (a) create a strategy to reduce the consumption of and (b) publish a report on the consumption of chewing tobacco primarily by South Asian women.
	tabling member constituency	Preston
	tabling member printed	Mr Mark Hendrick
	uin	9830
	answer	answer is ministerial correction date of answer 14/09/2017 answer text <p>Towards a smoke free generation: a tobacco control plan for England, sets out national ambitions to further reduce use of all tobacco products across the population in England. We have no plans to produce either a separate strategy to address, or a report on, the consumption of chewing tobacco by South Asian women.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 14/09/2017 13:50:10 answering member 4067 label Biography information for Steve Brine
	tabling member	473 label Biography information for Sir Mark Hendrick

781421

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on the medicine-taking behaviour of patients who rely on regular and multiple medications to prevent symptoms of long-term conditions.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110622
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110619 110620 110621 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781420

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Pre-payment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on patients with a long-term condition who have already purchased a prescription prepayment certificate.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110621
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110619 110620 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781417

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Illnesses: Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on patients with (a) inflammatory bowel disease and (b) a long-term condition.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110618
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110619 110620 110621 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781419

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Treatments: Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on access to medications for (a) children, (b) older people and (c) other vulnerable people.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110620
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110619 110621 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

781418

	registered interest
	date	31/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the proposals contained in the NHS England consultation entitled, Items which should not be routinely prescribed in primary care: A Consultation on guidance of CCGs, what assessment his Department has made of the potential effect of those proposals on (a) the management of urgent care services and (b) the number of hospital admissions.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	110619
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>NHS England’s consultation on draft guidance for clinical commissioning groups on a range of items that should not routinely be prescribed in primary care ended on 21 October. The draft guidance seeks to ensure that the National Health Service is able to secure best value from its use of medicines and therefore focuses on areas of prescribing that have been found to be ineffective or where there are more cost effective alternatives. A full Equality Impact Assessment was published alongside the draft guidance and a further Assessment will be published when final guidance is produced.</p><p> </p><p>We would not want to pre-empt any outcome following NHS England’s analysis of the responses it has received. However, we are assured that as part of issuing the final guidance, careful consideration will be given by NHS England to the responses to the consultation, both to ensure that particular groups of people are not disproportionately affected and that principles of best practice on clinical prescribing are adhered to.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110618 110620 110621 110622 question first answered 03/11/2017 14:35:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

746704

	registered interest
	date	29/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sugar
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the oral contribution by the former Under-Secretary of State for Health on 21 March 2017, Official Report, Column 775, what assessment he has made of the effect of the Food and Drink Federation's decision not to introduce the Government's 20 per cent optional reduction in sugar content in its members' products by 2020 on his Department's policies to tackle (a) childhood obesity and (b) childhood tooth decay.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	2048
	answer	answer is ministerial correction date of answer 04/07/2017 answer text <p>There has been no assessment made of the effect of Food and Drink Federation members’ compliance or non-compliance in achieving the 20% reduction in sugar content of key products contributing to children’s intakes by 2020 on childhood obesity or childhood tooth decay.</p><p> </p><p>In ‘Sugar reduction: The evidence for action’, published in October 2015, Public Health England (PHE) undertook modelling work to estimate the potential health impact and wider economic benefits of achieving the average population intake recommendation for sugar. This modelling found that achieving this over a 10-year period would result in 4,100 premature deaths and 204,000 cases of dental caries being averted, resulting in a total cost saving to the National Health Service of £484 million.</p><p> </p><p>PHE encourages all businesses to achieve the reductions in sugar as set out in ‘Childhood obesity: a plan for action’. A detailed assessment of industry’s progress will be published in March 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 04/07/2017 11:13:15 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

755820

	registered interest
	date	04/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the latest statistical bulletin published by the Office for National Statistics on deaths related to drug poisoning, what steps he is taking to address the disproportionately high drug mortality rate in the North East.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	7218
	answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>Local authorities are responsible for commissioning effective drug and alcohol prevention and treatment services based on an assessment of local need. Public Health England (PHE) supports local authorities to do this, by providing bespoke data, value for money tools, topical briefings, and advice on good practice to help local authorities meet the needs of their local population. In the North East, PHE work to help local areas prevent drug-related deaths includes:</p><p> </p><p>- running forums and networks to facilitate regional groups of commissioners, providers and service users working together, sharing practice and disseminating new policy and guidance;</p><p>- offering bespoke support packages to local authorities where necessary; and</p><p>- promoting the use of naloxone and training people how to use it across the North East.</p><p>Nationally, PHE has issued advice on providing naloxone, published updated clinical guidelines for drug treatment and worked with a network of treatment providers to establish good practice guidance on managing drug-related death risk factors and to improve partnership between treatment providers and other healthcare services.</p><p>PHE has also established a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas benchmark their performance against others.</p><p> </p><p>Ongoing national work by PHE to help prevent drug-related deaths includes:</p><p> </p><p>- helping local authorities improve their drug-related death review process;</p><p>- helping local authorities increase the number of people with drug problems who are in drug treatment; and</p><p>- improving intelligence on the adverse health effects of drugs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7238 7468 question first answered 12/09/2017 16:29:45 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris